Rez Gioz P.

Apego January 27, 2014

N-40
Patient’s name: Casugudan
Name of Classification of Mechanism of Action Indication Contraindications Side Effects Nursing Responsibilities
Drug Drug
Generic Therapeutic:  It enhances Adjuvant therapy in  Should not be  There are no such •Monitor for S&S of
Name: Mucolytic pulmonary patients with abnormal, used in harmful side effects aspiration of excess
Ambroxol surfactant viscid, or inspissated patients known of the medicine. It is secretions, and for
Hydrochlori Pregnancy production mucous secretions in to be usually well bronchospasm
de Category A and acute and chronic hypersensitiv e tolerated. In some (unpredictable);withhold
Trade Name: stimulates bronchopulmonary to ambroxol or cases, nausea and drug and notify physician
Mucosolvan ciliary activity. diseases, and in other vomiting might immediately if either occur.
and These actions pulmonary components of occur. •Lab tests: Monitor ABGs,
Mucoangin result in complications of cystic the pulmonary functions and
Availability: improved fibrosis and surgery, formulation. pulse oximetry as indicated.
Tablets—30 mucus flow tracheostomy, and  There are no •Have suction apparatus
mg; and transport atelectasis. absolute immediately available.
(mucociliary contraindicatio Increased volume of
clearance). n but in respiratory tract fluid may
Enhancement patients with be liberated; suction or
of fluid gastric endotracheal aspiration
secretion and ulceration may be necessary to
mucociliary relative establish and maintain an
clearance caution should open airway.
facilitates be observed. Patient & Family Education
expectoration •Report difficulty with
and eases clearing the airway or any
cough. other respiratory distress
Chief complaint: Cough and Fever